Research

Learning from the COVID-19 Policy Response

November 3, 2022

Learning from
This document is published by the World Economic Forum as a contribution to a project, insight area or interaction. The findings, interpretations and conclusions expressed herein are a result of a collaborative process facilitated and endorsed by the World Economic.

Spotlight

MTS, An Omnicell Company

MTS, An Omnicell Company, is headquartered in St.Petersburg, FL (USA). Founded in 1984 by a practicing pharmacist, MTS has grown into an international provider of medication adherence packaging systems designed to improve medication dispensing and administration. MTS understands the importance to pharmacies of maintaining high accuracy and quality standards while optimizing productivity and controlling costs.

OTHER WHITEPAPERS
news image

Drug Solubility and the Need for Speed

whitePaper | March 28, 2023

About 70% of new chemical entities (NCEs) are highly insoluble.1 It’s a fact that troubles small biotechnology companies and other drug manufacturers. Indeed, insoluble drugs present a wide range of challenges during development and, if not addressed, can ultimately render drugs ineffective in patients.

Read More
news image

Pharma R And D Review

whitePaper | February 11, 2021

Welcome to Pharmaprojects’ 2021 review of trends in pharmaceutical R&D. For almost 30 years now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article I’ll examine the state of play at the start of 2021.

Read More
news image

Artificial Intelligence in Drug Manufacturing

whitePaper | May 25, 2023

CDER’s mission is to ensure that human drugs are safe and effective, meet established quality standards, and are available to patients. To advance this mission, FDA’s Pharmaceutical Quality for the 21st Century Initiative promotes an efficient, agile, and flexible pharmaceutical manufacturing sector that reliably produces quality drugs without excessive regulatory oversight.

Read More
news image

Market Access Trends in the US, Europe, and Emerging Markets

whitePaper | November 14, 2022

Rising drug spending and increased desire for expenditure controls are consistent themes across the US, Europe, and emerging markets.

Read More
news image

Expediting early-phasedevelopment ofsmall molecules: Anintegrated approach

whitePaper | November 18, 2022

Small molecule drug development has changed substantially in recent years. With the heightened focus on molecularly targeted therapies, small molecule active pharmaceutical ingredients (APIs).

Read More
news image

The Use of Real-World Data for Personalized Medicine

whitePaper | June 5, 2022

Although our growing scientific understanding and improvements made in medical technology lead to significant advances in human health and wellbeing, many therapy strategies remain insufficient,

Read More

Spotlight

MTS, An Omnicell Company

MTS, An Omnicell Company, is headquartered in St.Petersburg, FL (USA). Founded in 1984 by a practicing pharmacist, MTS has grown into an international provider of medication adherence packaging systems designed to improve medication dispensing and administration. MTS understands the importance to pharmacies of maintaining high accuracy and quality standards while optimizing productivity and controlling costs.

Events